Aspirin increases platelet sensitivity to adenosine diphosphate in patients with coronary artery disease

Platelets

Volumn 10, Issue 2-3, 1999, Pages 191-192

  Kobzar, Gennadi ^a   Mardla, Vilja ^a   Rätsep, Indrek ^b  

^a TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

^b Mustamae Hospital   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0032931876     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109909169184     Document Type: Article

References (5)

1. 1. López-Farré A, Caramelo C, Esteban A, Alberola ML, Millás I, Montón M, Casado S. Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1. Circulation 1995; 91: 1080-8.
2. 2. Bozzo J, Hernándes MR, Ordinas A. Reduced red cell deformability associated with blood flow and platelet activation: improved by dipyridamole alone or combined with aspirin. Cardivasc Res 1995; 30: 725-30.
3. 3. Barstad RM, Orvim U, Hamers MJ, Tjinnfjord GE, Brosstand FR, Sakariassen KS. Reduced effects of aspirin on thrombus formation at high shear and disturbed laminar blood flow. Thromb Haemost 1996; 75: 827-32.
4. 4. Mazeaud MM, Levenson J, Le Quan Sang KH, Simon A, Devynck MA. Platelet aggregation and in vivo shear forces. Thromb Haemost 1994; 71: 26-31.
5. 5. Marcus AJ, Safier LB, Broekman MJ, Islam N, Fliessbach JH, Hajjar KA, Kaminski WE, Jerdraschak E, Silvertein RL, von Schacky C. Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions. Thromb Haemost 1995; 74: 213-7.